Cubist Systematic Strategies’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-32,021
| Closed | -$53.5K | – | 1428 |
|
|
2024
Q4 | $53.5K | Sell |
32,021
-351,491
| -92% | -$587K | ﹤0.01% | 1328 |
|
|
2024
Q3 | $698K | Buy |
383,512
+184,071
| +92% | +$335K | ﹤0.01% | 912 |
|
|
2024
Q2 | $1.2M | Buy |
+199,441
| New | +$1.2M | 0.01% | 719 |
|
|
2024
Q1 | – | Sell |
-65,814
| Closed | -$980K | – | 2188 |
|
|
2023
Q4 | $980K | Buy |
+65,814
| New | +$980K | 0.01% | 1119 |
|
|
2023
Q2 | – | Sell |
-33,869
| Closed | -$153K | – | 2245 |
|
|
2023
Q1 | $153K | Sell |
33,869
-2,472
| -7% | -$11.2K | ﹤0.01% | 2304 |
|
|
2022
Q4 | $410K | Sell |
36,341
-8,413
| -19% | -$94.8K | ﹤0.01% | 2290 |
|
|
2022
Q3 | $428K | Sell |
44,754
-42,585
| -49% | -$407K | ﹤0.01% | 2592 |
|
|
2022
Q2 | $707K | Buy |
87,339
+36,645
| +72% | +$297K | ﹤0.01% | 2360 |
|
|
2022
Q1 | $857K | Sell |
50,694
-9,801
| -16% | -$166K | 0.01% | 2152 |
|
|
2021
Q4 | $1.3M | Buy |
+60,495
| New | +$1.3M | 0.01% | 1713 |
|